Welcome, RFMJ! I agree that things should start progressing rather quickly, and am actually hoping for first dosing next week. One timeline piece where I disagree is I DON'T believe there will be an interim analysis. It seems there will be several clinical sites with total patient visit timeline only 29 days, so I expect recruitment of the 120 patients rapidly (within a few weeks) and then follow ups for 29 days. Since that all should happen quite quickly, locking the first 14-day data and gathering/analyzing/releasing isn't worth the delays and extra work/cost of simply completing the full trial and going through data lock/analysis/topline data release. I mostly agree with the rest of the timing of the trial you laid out.
I certainly share your optimism have continued buying the past few weeks.
Best of luck to Leo and all longs!